UNSPSC 51284034: Methacycline hydrochloride

This classification denotes a tetracycline antibiotic with the molecular formula C22H22N2O8.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9GJ0N7ZAP0, chemically known as 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride but more generally known as methacycline hydrochloride, which bears US NIH Compound Identifier 5281092. Most nations, for tariff and trade purposes, schedule methacycline hydrochloride under HS 29413000.

As of Q4 2014, METHACYCLINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Methacycline hydrochloride bears US NLM identifiers UMLS ID C0770655 and NCI Concept Code C47608. SMILES: CN(C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)C4CCCC(C4C(=O)C3=C([C@@]2(C(=O)C(=C1O)C(=O)N)O)O)O)O.CL.

UNSPSC 51284034 Methacycline hydrochloride is a Commodity code that encompasses pharmaceutical products, but recent state and local solicitations tagged under this code show minimal alignment with the specific product name — the code appears to serve as a catchall for broader pharmaceutical and medical supply procurement rather than purchases of methacycline hydrochloride specifically. State and local issuers soliciting under or near this code span health departments, municipal fire-rescue agencies, and cooperative purchasing alliances, with work ranging from naloxone and drug deactivation systems for community health programs to generic multi-source pharmaceuticals and over-the-counter products procured through state-managed wholesaler networks. The issuing-body mix includes county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health agencies (Texas HHS Commission), and regional cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving multiple states including Oregon). Recent solicitations show issuers seeking competitive bids on medical consumables with specific delivery and compliance requirements, including FDA registration, Good Manufacturing Practices certification, Drug Supply Chain Security Act compliance, and expiration-date minimums ranging from six months to nine months shelf life at acceptance.

Geographic activity concentrates in Florida, Texas, and the Upper Midwest through MMCAP's multistate network. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida; the City of Tampa's ITB 26-P-00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies supporting the Fire Department Rescue Division, estimated at $700,000.00 with a Small Local Business Enterprise set-aside and 5 percent bid discount; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers, with awards effective July 1, 2026. Texas HHS Commission also issued RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional PBM and GPO channels. The code shows activity but with limited volume transparency — only Tampa's solicitation names a dollar value ($700,000.00), while MMCAP and Texas HHS solicitations withhold award ranges.